Publications by authors named "J H Carraway"

Antibiotics are the primary drugs for combating infections, but with evolving antibiotic resistance of this bacterium, new druggable molecules are needed to stem the tide of this impending public health crisis. Propolis has long been recognized for its antimicrobial properties, being composed of secondary metabolites with antibacterial potential. We herein describe the evaluation of a Jamaican multifloral propolis for antibacterial activity against The bioassay-guided evaluation of the ethyl acetate extract yielded (+)-medicarpin (), whose final structure was elucidated based on spectral analysis and comparison with the known metabolites.

View Article and Find Full Text PDF

Background: Intensive Care Units (ICU) often initiate mechanical ventilation (MV) in conjunction with sedation for patients who cannot maintain adequate oxygenation or ventilation on their own. Continuous use of sedation increases the likelihood of negative events associated with ventilators such as ventilator-associated pneumonia while, at the same time, continuing to increase the length of MV.

Objectives: This study sought to analyze the effects of implementing a mandated Richmond Agitation and Sedation Scale (RASS) entry with each sedative scan on a unit where no parameters were in place to monitor sedation levels.

View Article and Find Full Text PDF
Article Synopsis
  • The ISO 10993 standards promote using validated in vitro methods over animal testing for biocompatibility of medical devices.
  • A round robin study tested in vitro reconstructed human epidermis (RhE) assays as alternatives to rabbit skin irritation tests, with RhE successfully identifying strong irritants but raising questions about accuracy compared to traditional tests.
  • Follow-up studies confirmed that RhE models yield results comparable to the more sensitive intracutaneous rabbit test, supporting their use as acceptable replacements for assessing the irritant potential of medical devices.
View Article and Find Full Text PDF

Amid growing efforts to advance the replacement, reduction, and refinement of the use of animals in research, there is a growing recognition that in vitro testing of medical devices can be more effective, both in terms of cost and time, and also more reliable than in vivo testing. Although the technological landscape has evolved rapidly in support of these concepts, regulatory acceptance of alternative testing methods has not kept pace. Despite the acceptance by regulators of some in vitro tests (cytotoxicity, gene toxicity, and some hemocompatibility assays), many toxicity tests still rely on animals (irritation, sensitization, acute toxicity, reproductive/developmental toxicity), even where other industrial sectors have already abandoned them.

View Article and Find Full Text PDF

We have previously described the use of a double coated agarose-agarose porcine islet macrobead for the treatment of type I diabetes mellitus. In the current study, the long-term viral safety of macrobead implantation into pancreatectomized diabetic dogs treated with pravastatin (n = 3) was assessed while 2 dogs served as nonimplanted controls. A more gradual return to preimplant insulin requirements occurred after a 2nd implant procedure (days 148, 189, and >652) when compared to a first macrobead implantation (days 9, 21, and 21) in all macrobead implanted animals.

View Article and Find Full Text PDF